Laboratorios Liomont S.A. de C.V

Founded in 1938, Laboratorios Liomont, S.A. de C.V. is a Mexican pharmaceutical manufacturer focused on medicines for human health. Its portfolio covers prescription and nonprescription products in therapeutic areas including analgesics and anti-inflammatory medicines, anti-infectives, cardiovascular care, dermatology, gastroenterology, respiratory care, diabetes, contraception, urology, dentistry, and vitamins. The company develops and manufactures medicines intended to address pain, inflammation, infections, weight management, allergy symptoms, digestive conditions, and other clinical and consumer health needs. Its Analgen family includes oral and topical analgesic and anti-inflammatory products for muscular pain, fever, menstrual discomfort, and related conditions.

Scientific research, technological development, and pharmaceutical manufacturing form the company’s operating foundation. Liomont develops monoclonal antibodies, biosimilars, advanced biotechnology solutions, and biotechnology vaccines, while maintaining production capabilities for sterile, biotechnology, and generic medicines. It operates three manufacturing plants, including facilities in Cuajimalpa and Ocoyoacac, and has administrative offices in Santa Fe, Mexico City. The company began exports in 1998 and reports a presence in 16 markets across the Americas and Europe. Its prescription medicines are certified to ISO 9001 quality standards, and its pharmacovigilance activity supports the reporting of adverse reactions associated with its products.